EPRX

Eupraxia Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 4/10
  • Momentum↑ 9/10
Eupraxia Pharmaceuticals sales and earnings growth
EPRX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 6.38%
  • FCF Y/Y↑ 16.07%
Eupraxia Pharmaceuticals gross and profit margin trends
EPRX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 20901.30%
Eupraxia Pharmaceuticals net debt vs free cash flow
EPRX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -214649.4

Eupraxia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗